BBA
Baker Bros. Advisors’s Acrivon Therapeutics ACRV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.1K | Hold |
22,809
| – | – | ﹤0.01% | 87 |
|
|
2025
Q1 | $46.3K | Sell |
22,809
-30,076
| -57% | -$61.1K | ﹤0.01% | 87 |
|
|
2024
Q4 | $318K | Hold |
52,885
| – | – | ﹤0.01% | 92 |
|
|
2024
Q3 | $370K | Hold |
52,885
| – | – | ﹤0.01% | 91 |
|
|
2024
Q2 | $307K | Hold |
52,885
| – | – | ﹤0.01% | 92 |
|
|
2024
Q1 | $378K | Buy |
+52,885
| New | +$378K | ﹤0.01% | 82 |
|